SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

RIGOLIN, Gian Matteo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 23.293
AS - Asia 13.555
EU - Europa 8.937
SA - Sud America 2.056
Continente sconosciuto - Info sul continente non disponibili 498
AF - Africa 266
OC - Oceania 35
AN - Antartide 1
Totale 48.641
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 22.630
SG - Singapore 4.936
CN - Cina 3.326
IT - Italia 2.762
BR - Brasile 1.574
VN - Vietnam 1.559
DE - Germania 1.387
UA - Ucraina 1.052
HK - Hong Kong 1.043
TR - Turchia 827
GB - Regno Unito 736
FR - Francia 673
FI - Finlandia 645
BD - Bangladesh 551
RU - Federazione Russa 365
SE - Svezia 363
JP - Giappone 357
CA - Canada 329
PL - Polonia 261
IN - India 258
MX - Messico 231
NL - Olanda 194
ID - Indonesia 186
AR - Argentina 178
ZA - Sudafrica 114
IQ - Iraq 90
BE - Belgio 85
ES - Italia 75
EC - Ecuador 71
CZ - Repubblica Ceca 68
CO - Colombia 63
PK - Pakistan 55
CL - Cile 52
UZ - Uzbekistan 51
LT - Lituania 47
MY - Malesia 46
VE - Venezuela 44
AT - Austria 43
AE - Emirati Arabi Uniti 37
SA - Arabia Saudita 37
PH - Filippine 34
IE - Irlanda 30
AU - Australia 29
MA - Marocco 29
PY - Paraguay 25
TN - Tunisia 25
KE - Kenya 21
JM - Giamaica 20
RO - Romania 20
DZ - Algeria 19
AZ - Azerbaigian 18
CH - Svizzera 18
EG - Egitto 18
PE - Perù 17
UY - Uruguay 17
IL - Israele 15
AL - Albania 13
BO - Bolivia 13
JO - Giordania 13
DO - Repubblica Dominicana 12
IR - Iran 12
LV - Lettonia 12
ET - Etiopia 11
HU - Ungheria 10
OM - Oman 10
SV - El Salvador 10
KR - Corea 9
KZ - Kazakistan 9
NP - Nepal 9
PT - Portogallo 9
RS - Serbia 9
YE - Yemen 9
DK - Danimarca 8
EU - Europa 8
PA - Panama 8
PS - Palestinian Territory 8
BG - Bulgaria 7
BY - Bielorussia 7
CR - Costa Rica 7
PR - Porto Rico 7
TH - Thailandia 7
GT - Guatemala 6
HR - Croazia 6
NI - Nicaragua 6
SI - Slovenia 6
GR - Grecia 5
HN - Honduras 5
KG - Kirghizistan 5
LB - Libano 5
NZ - Nuova Zelanda 5
TT - Trinidad e Tobago 5
AO - Angola 4
DM - Dominica 4
GE - Georgia 4
KW - Kuwait 4
MT - Malta 4
QA - Qatar 4
SN - Senegal 4
BB - Barbados 3
BH - Bahrain 3
Totale 48.081
Salva come PNG Salva come JPEG
Città #
Singapore 3.118
Ashburn 2.693
Woodbridge 1.780
Fairfield 1.673
San Jose 1.424
Houston 1.223
Beijing 1.167
Jacksonville 1.124
Chandler 1.099
Hong Kong 1.020
Santa Clara 1.012
Ann Arbor 790
Seattle 680
Wilmington 646
Cambridge 563
New York 523
Council Bluffs 506
Ho Chi Minh City 473
Los Angeles 460
Izmir 440
Dallas 417
Nanjing 370
Tokyo 340
Hanoi 335
Munich 310
Milan 299
Princeton 288
Ferrara 282
Helsinki 276
Lauterbourg 260
Warsaw 232
São Paulo 183
Shanghai 168
Boardman 160
San Diego 160
Rome 149
Mexico City 142
Buffalo 128
Orem 125
Jakarta 123
Turku 120
Nanchang 116
Toronto 116
Shenyang 114
Chicago 110
Dong Ket 108
London 101
Bremen 100
Addison 99
Montreal 90
Da Nang 82
Brussels 80
Tianjin 80
Denver 76
Hefei 76
Brooklyn 73
Bologna 70
Hebei 70
Jiaxing 68
Haiphong 67
Phoenix 65
Rio de Janeiro 63
Dearborn 62
Changsha 61
Johannesburg 61
Naples 61
Chennai 59
Moscow 59
Frankfurt am Main 57
San Francisco 53
Stockholm 51
Atlanta 49
Poplar 47
Jinan 46
Tashkent 46
Amsterdam 45
Boston 45
Falls Church 44
Manchester 44
Bari 42
Brno 42
Norwalk 41
Biên Hòa 39
Florence 37
Falkenstein 36
Redwood City 36
Zhengzhou 36
Guangzhou 34
Mountain View 34
Mumbai 34
San Mateo 34
The Dalles 34
Parma 33
Lappeenranta 32
Salt Lake City 32
Baghdad 31
Hải Dương 31
Brasília 30
Augusta 28
Verona 28
Totale 30.719
Salva come PNG Salva come JPEG
Nome #
Ripristino dell’apoptosi mediata da p53: ruolo degli inibitori di MDM2. 1.253
Fisiologia piastrinica. 365
Delirium in acute promyelocytic leukemia patients: Two case reports 355
In CLL, comorbidities and the complex karyotype are associated with an inferior outcome independently of CLL-IPI 316
Diagnostic work-up for clinical and prognostic assessment of acute leukaemia 296
Gene polymorphisms in folate metabolizing enzymes in adult acute lymphoblastic leukemia: effects on methotrexate-related toxicity and survival 294
Involvement of the P2X7-NLRP3 axis in leukemic cell proliferation and death 285
13q14 deletion in non-Hodgkin's lymphoma: Correlation with clinicopathologic features 282
Extensive next-generation sequencing analysis in chronic lymphocytic leukemia at diagnosis: Clinical and biological correlations 280
The anti-leukemic activity of sodium dichloroacetate in p53(mutated/null) cells is mediated by a p53-independent ILF3/p21 pathway 278
13q14 deletions in chronic lymphoproliferative disorders with the t(11;14)(q13;q32): a cytogenetic and interphase cytogenetic study. 277
A case of disseminated Langerhans' cell histiocytosis treated with thalidomide 275
Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia: Clinical and biologic correlations. 275
CYTOGENETIC ABERRATIONS IN THE CD38 POSITIVE FRACTION OF CD38 NEGATIVE CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) PATIENTS: A MARKER OF AGGRESSIVENESS? 274
An extensive molecular cytogenetic characterization in high-risk chronic lymphocytic leukemia identifies karyotype aberrations and TP53 disruption as predictors of outcome and chemorefractoriness 273
Sodium dichloroacetate exhibits anti-leukemic activity in B-chronic lymphocytic leukemia (B-CLL) and synergizes with the p53 activator Nutlin-3 273
CD34+ and endothelial progenitor cells in patients with various degrees of congestive heart failure 271
Ibrutinib synergizes with MDM-2 inhibitors in promoting cytotoxicity in B chronic lymphocytic leukemia 270
A highly sensitive and specific fluorescence in situ hybridization (FISH) approach for the detection of t(9;11)(p22-23;q23) in acute myeloid leukemia. 268
An extensive molecular cytogenetic characterization in high-risk chronic lymphocytic leukemia identifies karyotype aberrations and TP53 disruption as predictors of outcome and chemorefractoriness 268
A case of advanced Hodgkin lymphoma with breast involvement treated with a combination of gemcitabine and pegylated liposomal doxorubicin. 267
Identifying High-Risk Chronic Lymphocytic Leukemia: A Pathogenesis-Oriented Appraisal of Prognostic and Predictive Factors in Patients Treated with Chemotherapy with or without Immunotherapy 266
Chromosome aberrations in atypical chronic lymphocytic leukemia: a cytogenetic and interphase cytogenetic study 262
Chronic lymphocytic leukemia with 6q- shows distinct hematological features and intermediate prognosis 262
Clonal evolution including 14q32/IGH translocations in chronic lymphocytic leukemia: analysis of clinicobiologic correlations in 105 patients 261
Soluble urokinase-type Plasminogen Activator Receptor (suPAR) as an independent factor predicting worse prognosis and extra bone marrow involvement in multiple myeloma patients 255
In chronic lymphocytic leukaemia with complex karyotype, major structural abnormalities identify a subset of patients with inferior outcome and distinct biological characteristics 255
B-Cell chronic lymphocytic leukemia (B-CLL) with 14q32 translocations: haematological features and clinical outcome. 254
CLINICAL AND BIOLOGICAL CHARACTERIZATION OF CIRCULATING ENDOTHELIAL CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA 253
Acquired chromosome 11q deletion involving the ataxia teleangiectasia locus in B-cell non-Hodgkin's lymphoma: Correlation with clinicobiologic features 252
Clinical importance of interphase cytogenetics detecting occult chromosome lesions in myelodysplastic syndromes with normal karyotype 252
Interleukin-3 plus interleukin-6 may improve chromosomal analysis of multiple myeloma: Cytologic and cytogenetic evidence in thirty-four patients 250
Genetic subclonal complexity and miR125a-5p down-regulation identify a subset of patients with inferior outcome in low-risk CLL patients 249
Chromosome Aberrations by Conventional Karyotyping in Chronic Lymphocytic Leukemia Carrying No Aberration by Fluorescence in Situ Hybridization: Correlation with Prognostic Parameters and Clinical Features 249
Thrombosis of the cerebral veins and sinuses in acute promyelocytic leukemia after all-trans retinoic acid treatment: a case report. 243
Use of granulocyte-colony stimulating factor during acute myocardial infarction to enhance bone marrow stem cell mobilization in humans: clinical and angiographic safety profile 242
microRNAome Expression in Chronic Lymphocytic Leukemia: Comparison with Normal B-cell Subsets and Correlations with Prognostic and Clinical Parameters 240
Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia: Clinical and biologic correlations 239
In patients with myelodysplastic syndromes response to rHuEPO and G-CSF treatment is related to an increase of cytogenetically normal CD34+ cells 238
Fluorescence in situ hybridization for the detection and monitoring of the Ph-positive clone in chronic myelogenous leukemia: Comparison with metaphase banding analysis 236
Secondary chromosome changes in mantle cell lymphoma: Cytogenetic and fluorescence in situ hybridization studies 233
Exposure to myelotoxic agents and myelodysplasia: Case-control study and correlation with clinicobiological findings 233
Metformin combined with sodium dichloroacetate promotes B leukemic cell death by suppressing anti-apoptotic protein Mcl-1 231
Employment of Oligodeoxynucleotide plus Interleukin-2 Improves Cytogenetic Analysis in SplenicMarginal Zone Lymphoma 230
Neoplastic circulating endothelial cells in multiple myeloma with 13q14 deletion 229
Endothelium-mediated survival of leukemic cells and angiogenesis-related factors are affected by lenalidomide treatment in chronic lymphocytic leukemia 228
The p53 transcriptional pathway is preserved in ATMmutated and NOTCH1mutated chronic lymphocytic leukemias 227
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS IN A PATIENT WITH RELAPSED CHRONIC LYMPHOCYTIC LEUKEMIA TREATED WITH IBRUTINIB 227
Biological significance and prognostic/predictive impact of complex karyotype in chronic lymphocytic leukemia 227
Alterazioni cromosomiche in cellule staminali emopoietiche indotte da esposizioni ambientali o professionali. 226
A Prospective, Multi Center Phase II Study Evaluating Predictive Factors for Lenalidomide Treatment in Relapse or Refractory Chronic Lymphocytic Leukemia Patients (LE.P.RE.): Preliminary Results about the First 20 Enrolled Patients 226
Erratum to: Extensive next-generation sequencing analysis in chronic lymphocytic leukemia at diagnosis: clinical and biological correlations (J Hematol Oncol. (2016) 9 (88) DOI:10.1186/s13045-016-0320-z) 225
Dendritic cells and vascular endothelial growth factor in colorectal cancer: Correlations with clinicobiological findings 225
Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia with "normal" FISH: Correlations with clinicobiologic parameters 225
Isolated thrombocytopenia by splenic sequestration in hemodialyzed patients 224
Identifying High-Risk Chronic Lymphocytic Leukemia: A Reappraisal of the Impact of Prognostic and Predictive Factors 223
A randomized double-blind placebo-controlled study with subcutaneous recombinant human erythropoietin in patients with low-risk myelodysplastic syndromes 222
Chronic Lymphocytic Leukemia: Prognostic Factors in the Era of Novel Drugs 222
A highly sensitive and specific fluorescence in situ hybridization (FISH) approach for the detection of t(9;11)(p22-23;q23) in acute myeloid leukemia. 221
Atypical chronic lymphocytic leukaemia with t(11;14)(q13;q32): karyotype evolution and prolymphocytic transformation 217
REFINED KARYOTYPE-BASED PROGNOSTIC STRATIFICATION OF CHRONIC LYMPHOCYTIC LEUKEMIA WITH A VERY LOW RISK GENETIC PROFILE 216
Chromosome 14q32 translocations involving the immunoglobulin heavy chain locus in chronic lymphocytic leukaemia identify a disease subset with poor prognosis 216
Response to ibrutinib of a refractory IgA lymphoplasmacytic lymphoma carrying the MYD88 L265P gene mutation 215
Differentiation of follicular dendritic sarcoma cells into functional myeloiddendritic cell-like elements 213
Cellule endoteliali progenitrici e grado di attività fisica in una popolazione di pazienti nefropatici emodializzati 210
Richter's syndrome in a case of atypical chronic lymphocytic leukaemia with the t(11;14)(q13;q32): role for a p53 exon 7 gene mutation 210
BCR/ABL1-positive acute lymphoblastic leukemia relapsing as BCR/ABL1-negative acute lymphoblastic leukemia 209
Neoplastic circulating endothelial-like cells in patients with acute myeloid leukaemia 208
Peripheral T-cell lymphoma not otherwise specified (PTCL-NOS) 205
LATE APPEARANCE of 14q32/IGH TRANSLOCATION In CHRONIC LYMPHOCYTIC LEUKEMIA. 205
Dendritic cell recovery after allogeneic stem-cell transplantation in acute leukemia: Correlations with clinical and transplant characteristics 205
“Hemophagocytic Lymphohistiocytosis after EBV reactivation and ibrutinib treatment in relapsed/refractory Chronic Lymphocytic Leukemia” 203
Flow cytometric detection of accelerated telomere shortening in myelodysplastic syndromes: Correlations with aetiological and clinical-biological findings 203
Abnormalities of chromosomes 1p34-36, 4p16, 4q35, 9q11-32 and +7 represent novel recurrent cytogenetic rearrangements in chronic lymphocytic leukemia 203
Hsa-miR-15a and Hsa-miR-16-1 expression is not related to proliferation centers abundance and other prognostic factors in chronic lymphocytic leukemia 202
Dendritic cells in acute promyelocytic leukaemia 201
Cytogenetic profile of lymphoma of follicle mantle lineage: Correlation with clinicobiologic features 201
Cytogenetic and interphase cytogenetic characterization of atypical chronic lymphocytic leukemia carrying BCL1 translocation 201
Circulating endothelial cells in patients with chronic lymphocytic leukemia: clinical-prognostic and biological significance 199
Circulating endothelial stem cells are not decreased in pulmonary emphysema or COPD 199
In chronic lymphocytic leukaemia, SLAMF1 deregulation is associated with genomic complexity and independently predicts a worse outcome 198
A Molecular Model to Predict Durable Remission after First Line Fludarabine-Cyclophosphamide-Rituximab Treatment in Chronic Lymphocytic Leukemia 197
Grave colestasi di origine paraneoplastica in donna ultraottantenne con linfoma B-cellulare anaplastico misconosciuto [Severe paraneoplastic cholestasis in a octogenarian woman with unrecognized anaplastic B-cell lymphoma] 196
Refined karyotype-based prognostic stratification of chronic lymphocytic leukemia with a low- and very-low-risk genetic profile 196
CLINICAL AND BIOLOGICAL CHARACTERIZATION OF CIRCULATING ENDOTHELIAL CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA 195
Molecular prediction of durable remission after first-line fludarabine-cyclophosphamide-rituximab in chronic lymphocytic leukemia 195
Mobilization of endothelial progenitor cells in patients with hematological malignancies after treatment with granulocyte colony stimulating factor and chemotherapy for autologous transplantation 194
Hepatosplenic T-cell lymphoma (HSTCL). 194
INTEGRATION OF NOVEL GENE MUTATIONS INTO KARYOTYPE-BASED SUBGROUPS AS A PROGNOSTIC RISK STRATIFICATION TOOL IN CHRONIC LYMPHOCYTIC LEUKEMIA 194
Clonal evolution in chronic lymphocytic leukemia: analysis of clinicobiologic correlations in 105 patients 194
Exercise capacity and circulating endothelial progenitor cells in hemodialysis patients 193
Minimal morphological criteria for defining bone marrow dysplasia: A basis for clinical implementation of WHO classification of myelodysplastic syndromes 193
Mobilization of endothelial progenitor cells in patientes with haematological malignancies after treatment with filgrastim and chemotherapy for autologous transplantation 193
Multilineage involvement in the 5q- syndrome: A fluorescent in situ hybridization study on bone marrow smears 192
Hemophagocytic Lymphohistiocytosis in a Patient with Relapsed Chronic Lymphocytic Leukemia Treated with Ibrutinib 192
Flow cytometry measurement of GM-CSF receptors in acute leukemic blasts, and normal hemopoietic cells 190
Exercise training and endothelial progenitor cells in haemodialysis patients 189
The combination of complex karyotype subtypes and IGHV mutational status identifies new prognostic and predictive groups in chronic lymphocytic leukaemia 185
Circulating Endothelial Stem Cells in Age-Matched Smokers with or without Mild-to-Moderate Pulmonary Emphysema 184
Increased SHISA3 expression characterizes chronic lymphocytic leukemia patients sensitive to lenalidomide 184
Totale 24.246
Salva come PNG Salva come JPEG
Categoria #
all - tutte 219.684
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 32.004
Totale 251.688
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.649 0 338 119 141 217 146 156 164 96 243 255 774
2022/20232.771 334 144 108 304 459 371 128 273 380 25 164 81
2023/20241.610 138 155 76 50 99 244 74 98 38 50 114 474
2024/20256.513 182 174 543 283 814 579 206 302 1.005 799 834 792
2025/202619.202 1.652 908 1.525 2.474 2.643 1.244 2.088 1.097 1.788 2.110 918 755
2026/20271.173 713 460 0 0 0 0 0 0 0 0 0 0
Totale 48.641